- Home
- TIGO vs JAZZ Comparison
TIGO vs JAZZ Comparison
Compare TIGO & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGO
- JAZZ
- Stock Information
- Founded
- TIGO 1990
- JAZZ 2003
- Country
- TIGO Luxembourg
- JAZZ Ireland
- Employees
- TIGO N/A
- JAZZ N/A
- Industry
- TIGO Telecommunications Equipment
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- TIGO Telecommunications
- JAZZ Health Care
- Exchange
- TIGO Nasdaq
- JAZZ Nasdaq
- Market Cap
- TIGO 8.1B
- JAZZ 7.7B
- IPO Year
- TIGO 1994
- JAZZ 2007
- Fundamental
- Price
- TIGO $47.53
- JAZZ $126.16
- Analyst Decision
- TIGO Hold
- JAZZ Strong Buy
- Analyst Count
- TIGO 5
- JAZZ 14
- Target Price
- TIGO $43.62
- JAZZ $178.93
- AVG Volume (30 Days)
- TIGO 1.1M
- JAZZ 699.5K
- Earning Date
- TIGO 11-06-2025
- JAZZ 11-05-2025
- Dividend Yield
- TIGO 6.30%
- JAZZ N/A
- EPS Growth
- TIGO 792.62
- JAZZ N/A
- EPS
- TIGO 5.57
- JAZZ N/A
- Revenue
- TIGO $5,605,000,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- TIGO N/A
- JAZZ $5.65
- Revenue Next Year
- TIGO $7.52
- JAZZ $5.79
- P/E Ratio
- TIGO $8.44
- JAZZ N/A
- Revenue Growth
- TIGO N/A
- JAZZ 4.52
- 52 Week Low
- TIGO $23.61
- JAZZ $95.49
- 52 Week High
- TIGO $50.78
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- TIGO 58.49
- JAZZ 56.13
- Support Level
- TIGO $45.48
- JAZZ $125.33
- Resistance Level
- TIGO $48.45
- JAZZ $129.50
- Average True Range (ATR)
- TIGO 1.49
- JAZZ 3.04
- MACD
- TIGO -0.34
- JAZZ -0.33
- Stochastic Oscillator
- TIGO 38.68
- JAZZ 34.86
About TIGO Millicom International Cellular S.A.
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to acquire Telefonica's operations in Ecuador and Uruguay.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.